Results: 60

    Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews

    The ongoing COVID-19 disease pandemic (caused by SARS-Cov 2), with associated mortality and morbidity, has prompted a focus on the efforts to develop vaccines and treatments. While the clinical presentation of COVID-19 ranges from asymptomatic to fulminant and fatal, severe cases of infection can develop...

    Using evidence-informed policies to tackle overweight and obesity in Chile

    Overweight and obesity are a global epidemic with rates having risen to alarming levels in both developed and developing countries. Chile has been no exemption, with sharp increases in obesity prevalence, especially among school-age children. This paper describes the policy actions and strategies impleme...

    The Evidence-Informed Policy Network (EVIPNet) in Chile: lessons learned from a year of coordinated efforts

    Informing the health policymaking process with the best available scientific evidence has become relevant to health systems globally. Knowledge Translation Platforms (KTP), such as the World Health Organization's Evidence Informed Policy Networks (EVIPNet), are a recognized strategy for linking research ...

    The implementation of the bioequivalence certification policy in Chile: an analysis of market authorization data

    PLoS One; 14 (5), 2019
    Affordability is a key barrier to access to medicines. Generic medicines policies can address this barrier and promote access. Successful uptake of generic medicines depends, in part, on ensuring that these products are interchangeable with reference products. Typically, bioequivalence certification is e...

    3. 2 million stillbirths: epidemiology and overview of the evidence review

    More than 3.2 million stillbirths occur globally each year, yet stillbirths are largely invisible in global data tracking, policy dialogue and programme implementation. This mismatch of burden to action is due to a number of factors that keep stillbirths hidden, notably a lack of data and a lack of conse...

    The effectiveness of evidence summaries on health policymakers and health system managers use of evidence from systematic reviews: a systematic review

    Systematic reviews are important for decision makers. They offer many potential benefits but are often written in technical language, are too long, and do not contain contextual details which make them hard to use for decision-making. There are many organizations that develop and disseminate derivative p...

    Costs and cost-effectiveness of community health workers: evidence from a literature review

    This study sought to synthesize and critically review evidence on costs and cost-effectiveness of community health worker (CHW) programmes in low- and middle-income countries (LMICs) to inform policy dialogue around their role in health systems....

    Chlorpyrifos and neurodevelopmental effects: a literature review and expert elicitation on research and policy

    Organophosphate pesticides are widely used on food crops grown in the EU. While they have been banned from indoor use in the US for a decade due to adverse health effects, they are still the most prevalent pesticides in the EU, with Chlorpyrifos (CPF) being the most commonly applied. It has been suggeste...

    Barriers, facilitators, strategies and outcomes to engaging policymakers, healthcare managers and policy analysts in knowledge synthesis: a scoping review protocol

    Engaging policymakers, healthcare managers and policy analysts in the conduct of knowledge synthesis can help increase its impact. This is particularly important for knowledge synthesis studies commissioned by decision-makers with limited timelines, as well as reviews of health policy and systems researc...

    Utility of social media and crowd-sourced data for pharmacovigilance: a scoping review protocol

    : Adverse events associated with medications are under-reported in postmarketing surveillance systems. A systematic review of published data from 37 studies worldwide (including Canada) found the median under-reporting rate of adverse events to be 94% in spontaneous reporting systems. This scoping review...